Amica Mutual Insurance Company Trimmed Its Stake in Equinix (EQIX) by $1.50 Million; Daiwa Securities Group Raised Celgene (CELG) Position by $3.85 Million

Amica Mutual Insurance Company decreased its stake in Equinix Inc (EQIX) by 34.17% based on its latest 2019Q1 regulatory filing with the SEC. Amica Mutual Insurance Company sold 3,316 shares as the company’s stock rose 24.17% with the market. The institutional investor held 6,389 shares of the consumer services company at the end of 2019Q1, valued at $2.90M, down from 9,705 at the end of the previous reported quarter. Amica Mutual Insurance Company who had been investing in Equinix Inc for a number of months, seems to be less bullish one the $42.13 billion market cap company. The stock decreased 0.62% or $3.13 during the last trading session, reaching $501.16. About 196,542 shares traded. Equinix, Inc. (NASDAQ:EQIX) has risen 22.28% since July 1, 2018 and is uptrending. It has outperformed by 17.85% the S&P500.

Daiwa Securities Group Inc increased its stake in Celgene (CELG) by 416.12% based on its latest 2019Q1 regulatory filing with the SEC. Daiwa Securities Group Inc bought 40,946 shares as the company’s stock rose 5.82% with the market. The institutional investor held 50,786 shares of the major pharmaceuticals company at the end of 2019Q1, valued at $4.79M, up from 9,840 at the end of the previous reported quarter. Daiwa Securities Group Inc who had been investing in Celgene for a number of months, seems to be bullish on the $65.74B market cap company. The stock increased 0.84% or $0.78 during the last trading session, reaching $93.22. About 2.74 million shares traded. Celgene Corporation (NASDAQ:CELG) has risen 11.31% since July 1, 2018 and is uptrending. It has outperformed by 6.88% the S&P500. Some Historical CELG News: 16/04/2018 - IN CHECKMATE -141, OPDIVO (NIVOLUMAB) DEMONSTRATED SUSTAINED OVERALL SURVIVAL (OS) ADVANTAGE OVER STANDARD OF CARE IN PATIENTS WITH RECURRENT OR METASTATIC SQUAMOUS CELL CARCINOMA OF THE HEAD AND…; 23/05/2018 - MERCK & CO - SUBMITTED SBLA FOR KEYTRUDA IN COMBINATION TO U.S. FDA AND NEW DATA WILL BE SHARED WITH AGENCY; 06/03/2018 - Bristol-Myers: Opdivo Dosing Now Includes 480 Mg Infused Every Four Weeks for Majority of Approved Indications; 28/03/2018 - BLUEBIRD BIO-CELGENE TO CO-DEVELOP BB2121 IN UNITED STATES; 08/05/2018 - ONCOSEC MEDICAL SAYS UNDER COLLABORATION AGREEMENT, ONCOSEC WILL SPONSOR, FUND STUDY AND MERCK WILL PROVIDE KEYTRUDA; 04/05/2018 - Celgene 1Q Adj EPS $2.05; 02/04/2018 - Command and control: In sudden revamp, Celgene CEO Alles bids his COO goodbye and looks to regain confidence with management shuffle $CELG; 19/04/2018 - Celgene Corporation Announces Changes to Its Board of Directors; 04/05/2018 - Celgene Delivers No-Drama Quarter Following Series of Setbacks; 02/04/2018 - Aeglea BioTherapeutics Doses First Small Cell Lung Cancer Patients with Pegzilarginase in Both Monotherapy and KEYTRUDA® (Pembrolizumab) Combination Trials

Daiwa Securities Group Inc, which manages about $11.45B US Long portfolio, decreased its stake in Cousins Pptys (NYSE:CUZ) by 3.51M shares to 9.11M shares, valued at $87.98 million in 2019Q1, according to the filing. It also reduced its holding in Adobe (Prn) (NASDAQ:ADBE) by 6,532 shares in the quarter, leaving it with 3,573 shares, and cut its stake in Bluebird Bio (NASDAQ:BLUE).

Since February 7, 2019, it had 0 insider buys, and 1 sale for $2.05 million activity.

Investors sentiment increased to 0.76 in 2019 Q1. Its up 0.12, from 0.64 in 2018Q4. It increased, as 108 investors sold CELG shares while 441 reduced holdings. 204 funds opened positions while 213 raised stakes. 482.72 million shares or 1.75% less from 491.33 million shares in 2018Q4 were reported. Archford Capital Strategies Limited Liability Company reported 272 shares. Budros Ruhlin And Roe Inc invested in 3,401 shares. Pub Sector Pension Inv Board has invested 0.05% in Celgene Corporation (NASDAQ:CELG). Kcm Inv Advisors Ltd Company stated it has 2,979 shares. Gam Ag reported 196,914 shares. Fulton Savings Bank Na reported 0.18% stake. Baldwin Brothers Inc Ma has invested 0.01% in Celgene Corporation (NASDAQ:CELG). Moreover, Douglass Winthrop Advsr Limited Com has 0.02% invested in Celgene Corporation (NASDAQ:CELG). Rmb Management Lc stated it has 0.01% in Celgene Corporation (NASDAQ:CELG). Natl Bank Of The West reported 0.13% in Celgene Corporation (NASDAQ:CELG). Doliver LP has 0.14% invested in Celgene Corporation (NASDAQ:CELG) for 3,773 shares. Woodstock Corporation holds 93,605 shares. Keybank Association Oh holds 0.13% or 225,280 shares in its portfolio. Utah Retirement has 0.25% invested in Celgene Corporation (NASDAQ:CELG) for 132,611 shares. Telemus Cap Ltd Liability Corporation holds 13,982 shares.

More notable recent Celgene Corporation (NASDAQ:CELG) news were published by: Nasdaq.com which released: “Pharma Stock Roundup: ABBV to Buy AGN, BMY to Sell CELG’s Otezla to Close Merger - Nasdaq” on June 28, 2019, also Streetinsider.com with their article: “Celgene (CELG), Acceleron Pharma (XLRN) Announce FDA Accepts Luspatercept BLA in Myelodysplastic Syndromes and Beta-Thalassemia - StreetInsider.com” published on June 04, 2019, Nasdaq.com published: “Notable Monday Option Activity: HAL, ADBE, CELG - Nasdaq” on June 24, 2019. More interesting news about Celgene Corporation (NASDAQ:CELG) were released by: Nasdaq.com and their article: “Why These Innovative Biotech ETFs Soaring - Nasdaq” published on June 24, 2019 as well as Fool.com‘s news article titled: “Where Will bluebird bio Be in 1 Year? - The Motley Fool” with publication date: June 21, 2019.

Investors sentiment increased to 1.83 in Q1 2019. Its up 0.63, from 1.2 in 2018Q4. It is positive, as 33 investors sold EQIX shares while 141 reduced holdings. 77 funds opened positions while 242 raised stakes. 78.95 million shares or 0.67% more from 78.42 million shares in 2018Q4 were reported. Georgia-based Advisory Ser Ntwk Ltd has invested 0.01% in Equinix, Inc. (NASDAQ:REIT). State Of Alaska Department Of Revenue reported 0.32% of its portfolio in Equinix, Inc. (NASDAQ:REIT). Prudential Public Limited invested in 0.22% or 140,569 shares. Bb&T Securities Limited Liability Corp reported 0.01% in Equinix, Inc. (NASDAQ:REIT). Capital Fund Management holds 51,245 shares or 0.16% of its portfolio. Cbre Clarion Ltd invested 3.83% of its portfolio in Equinix, Inc. (NASDAQ:REIT). Schroder Invest Mgmt Grp holds 0.02% in Equinix, Inc. (NASDAQ:REIT) or 28,469 shares. Cumberland Ltd has 1,600 shares for 0.07% of their portfolio. Korea invested in 90,610 shares or 0.18% of the stock. Neuberger Berman Gp Limited Liability Corp holds 0.09% of its portfolio in Equinix, Inc. (NASDAQ:REIT) for 168,383 shares. Highland Cap Mgmt Ltd Llc holds 0.06% or 1,849 shares in its portfolio. Brinker Capital reported 0.32% stake. Whittier reported 0.04% of its portfolio in Equinix, Inc. (NASDAQ:REIT). Nordea Mngmt owns 0.01% invested in Equinix, Inc. (NASDAQ:REIT) for 5,550 shares. Gateway Advisers Lc accumulated 0.01% or 3,583 shares.

More notable recent Equinix, Inc. (NASDAQ:REIT) news were published by: Nasdaq.com which released: “Retail Opportunity Investments Corp. Schedules Second Quarter Earnings Release and Conference Call - Nasdaq” on June 13, 2019, also Nasdaq.com with their article: “These 5 REITs Paying Up to 7.0% Will Soar as Rates Fall - Nasdaq” published on June 14, 2019, Nasdaq.com published: “3 Dividend Stocks That Are Perfect for Retirees - Nasdaq” on July 01, 2019. More interesting news about Equinix, Inc. (NASDAQ:REIT) were released by: Nasdaq.com and their article: “Here’s Why You Should Hold AvalonBay (AVB) Stock Right Now - Nasdaq” published on June 19, 2019 as well as Nasdaq.com‘s news article titled: “Ventas, Inc. (VTR) Ex-Dividend Date Scheduled for June 28, 2019 - Nasdaq” with publication date: June 27, 2019.

Amica Mutual Insurance Company, which manages about $799.84 million US Long portfolio, upped its stake in Hcp Inc (NYSE:HCP) by 26,822 shares to 77,441 shares, valued at $2.42M in 2019Q1, according to the filing. It also increased its holding in Equity Residential (NYSE:EQR) by 10,419 shares in the quarter, for a total of 37,162 shares, and has risen its stake in Cerner Corporation (NASDAQ:CERN).

Since January 15, 2019, it had 0 buys, and 6 sales for $6.89 million activity. $1.47 million worth of Equinix, Inc. (NASDAQ:REIT) was sold by STROHMEYER KARL on Tuesday, January 15. VAN CAMP PETER had sold 1,257 shares worth $478,833. 5,648 shares were sold by Meyers Charles J, worth $2.15M on Tuesday, January 15. $366,798 worth of stock was sold by Campbell Michael Earl on Tuesday, January 15. The insider Schwartz Eric sold 3,551 shares worth $1.35 million.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.